The Relationship of Lymphocyte to High-Density Lipoprotein Ratio with Pulmonary Function in COPD

References

• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582.28128970
   PubMed Web of Science ®Google Scholar
• SorianoJB, AbajobirAA, AbateKH, Collaborators, G.B.D.C.R.D. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X28822787
   PubMed Web of Science ®Google Scholar
• BarnesPJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. doi:10.1016/j.jaci.2016.05.01127373322
   PubMed Web of Science ®Google Scholar
• AcanforaD, ScicchitanoP, CaroneM, et al. Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD. BMC Pulm Med. 2018;18(1):116. doi:10.1186/s12890-018-0685-630005642
   PubMed Web of Science ®Google Scholar
• PaliogiannisP, FoisAG, SotgiaS, et al. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev. 2018;27(147):147. doi:10.1183/16000617.0113-2017
   Web of Science ®Google Scholar
• Pascual-GonzalezY, López-SánchezM, DorcaJ, et al. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2018;13:3651–3662. doi:10.2147/COPD.S17806830464448
   PubMed Web of Science ®Google Scholar
• KaradenizG, AktoğuS, ErerOF, et al. Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease. Biomark Med. 2016;10(7):701–710. doi:10.2217/bmm-2016-004627339097
   PubMed Web of Science ®Google Scholar
• GunayE, UlaşlıSS, AkarO, AhsenA, GünayS, KoyuncuT, ÜnlüM. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014;37(2):374–380.24078279
   PubMed Web of Science ®Google Scholar
• GunayS, SariaydinM, AcayA. New predictor of atherosclerosis in subjects with COPD: atherogenic indices. Respir Care. 2016;61(11):1481–1487. doi:10.4187/respcare.0479627507177
   PubMed Web of Science ®Google Scholar
• ParkJH, MunS, ChoiDP, et al. Association between high-density lipoprotein cholesterol level and pulmonary function in healthy Korean adolescents: the JS high school study. BMC Pulm Med. 2017;17(1):190. doi:10.1186/s12890-017-0548-629228928
   PubMed Web of Science ®Google Scholar
• GordonEM, FigueroaDM, BarochiaAV, et al. High-density lipoproteins and apolipoprotein A-I: potential new players in the prevention and treatment of lung disease. Front Pharmacol. 2016;7:323. doi:10.3389/fphar.2016.0032327708582
   PubMed Web of Science ®Google Scholar
• ChenH, XiongC, ShaoX, et al. Lymphocyte to high-density lipoprotein ratio as a new indicator of inflammation and metabolic syndrome. Diabetes Metab Syndr Obes. 2019;12:2117–2123. doi:10.2147/DMSO.S21936331686883
   PubMed Web of Science ®Google Scholar
• BackmanH, ErikssonB, RönmarkE, et al. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016;114:103–110.27109819
   PubMed Web of Science ®Google Scholar
• MirzaS, ClayRD, KoslowMA, et al. COPD guidelines: a review of the 2018 GOLD report. Mayo Clin Proc. 2018;93(10):1488–1502. doi:10.1016/j.mayocp.2018.05.02630286833
   PubMed Web of Science ®Google Scholar
• ViinanenA, LasseniusMI, ToppilaI, et al. The burden of Chronic Obstructive Pulmonary Disease (COPD) in Finland: impact of disease severity and eosinophil count on healthcare resource utilization. Int J Chron Obstruct Pulmon Dis. 2019;14:2409–2421. doi:10.2147/COPD.S22258131749614
   PubMed Web of Science ®Google Scholar
• JonesPW, QuirkFH, BaveystockCM, et al. A self-complete measure of health status for chronic airflow limitation: the St. George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.13211595997
   PubMed Web of Science ®Google Scholar
• CelliBR, CoteCG, MarinJM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa02132214999112
   PubMed Web of Science ®Google Scholar
• WangY, XuJ, MengY, et al. Role of inflammatory cells in airway remodeling in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3341–3348. doi:10.2147/COPD.S17612230349237
   PubMed Web of Science ®Google Scholar
• Matsuzawa-IshimotoY, HwangS, CadwellK. Autophagy and inflammation. Annu Rev Immunol. 2018;36(1):73–101. doi:10.1146/annurev-immunol-042617-05325329144836
   PubMed Web of Science ®Google Scholar
• SahinF, KoşarAF, AslanAF, et al. Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a comparative study. J Med Biochem. 2019;38(4):503–511. doi:10.2478/jomb-2018-005031496916
   PubMed Web of Science ®Google Scholar
• Leandro-MerhiVA, CostaCL, SaragiottoL, et al. Nutritional indicators of malnutrition in hospitalized patients. Arq Gastroenterol. 2019;56(4):447–450. doi:10.1590/s0004-2803.201900000-7431618398
   PubMedGoogle Scholar
• CollinsPF, EliaM, KurukulaaratchyRJ, et al. The influence of deprivation on malnutrition risk in outpatients with chronic obstructive pulmonary disease (COPD). Clin Nutr. 2018;37(1):144–148. doi:10.1016/j.clnu.2016.11.00527866758
   PubMed Web of Science ®Google Scholar
• QaisarR, KarimA, MuhammadT. Circulating biomarkers of handgrip strength and lung function in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:311–321. doi:10.2147/COPD.S22576532103930
   PubMed Web of Science ®Google Scholar
• ReedRM, IaconoA, DeFilippisA, et al. Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol. J Heart Lung Transplant. 2011;30(6):674–678. doi:10.1016/j.healun.2010.12.01021306919
   PubMed Web of Science ®Google Scholar
• Huerta-RamirezS, Paniagua-PérezA, Castro-SernaD, Ledesma-VelázquezA, Rubio-GuerraA, Vargas-AyalaG. Effect of the components of the metabolic syndrome on pulmonary function. The unexpected role of high-density lipoprotein cholesterol. Cir Cir. 2018;86(2):175–181.29809185
   PubMed Web of Science ®Google Scholar
• Namiri-KalantariR, GaoF, ChattopadhyayA, et al. The dual nature of HDL: anti-inflammatory and pro-inflammatory. Biofactors. 2016;7(3):153–159. doi:10.1002/biof.1205
   Web of Science ®Google Scholar
• LiH, LiuY, WangL, et al. High apolipoprotein M serum levels correlate with chronic obstructive pulmonary disease. Lipids Health Dis. 2017;5(1):59. doi:10.1186/s12944-016-0228-1
   Web of Science ®Google Scholar
• BurkartKM, ManichaikulA, WilkJB, et al. APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema. Eur Respir J. 2020;15(4):311–321. doi:10.1183/09031936.00147612
   Web of Science ®Google Scholar
• LeeSJ, LeeHR, LeeTW, et al. Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study. Korean J Intern Med. 2016;31(5):891–898. doi:10.3904/kjim.2015.08427017385
   PubMed Web of Science ®Google Scholar
• CamiciottoliG, BigazziF, BartolucciM, et al. BODE-index, modified BODE-index and ADO-score in chronic obstructive pulmonary disease: relationship with COPD phenotypes and CT lung density changes. COPD. 2012;9(3):297–304. doi:10.3109/15412555.2012.66100022432964
   PubMedGoogle Scholar
• DonariaL, MesquitaR, MartinezL, et al. Relationship between sniff nasal inspiratory pressure and BODE index in patients with COPD. Lung. 2014;192(6):897–903. doi:10.1007/s00408-014-9649-725270517
   PubMed Web of Science ®Google Scholar
• Folch AyoraA, Macia-SolerL, Orts-CortésMI, et al. Comparative analysis of the psychometric parameters of two quality-of-life questionnaires, the SGRQ and CAT, in the assessment of patients with COPD exacerbations during hospitalization: a multicenter study. Chron Respir Dis. 2018;15(4):374–383. doi:10.1177/147997231876164529529879
   PubMed Web of Science ®Google Scholar
• NakamuraK, BarziF, HuxleyR, et al. Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases? Heart. 2009;95(11):909–916. doi:10.1136/hrt.2008.14706619196734
   PubMed Web of Science ®Google Scholar
• GepnerAD, PiperME, JohnsonHM, et al. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J. 2011;161(1):145–151. doi:10.1016/j.ahj.2010.09.02321167347
   PubMed Web of Science ®Google Scholar
• HeB-M, ZhaoS-P, PengZ-Y. Effects of cigarette smoking on HDL quantity and function: implications for atherosclerosis. J Cell Biochem. 2013;114(11):2431–2436. doi:10.1002/jcb.2458123852759
   PubMed Web of Science ®Google Scholar
• BecklakeMR, LallooU. The ‘healthy smoker’: a phenomenon of health selection? Respiration. 1990;57(3):137–144. doi:10.1159/0001958372274712
   PubMed Web of Science ®Google Scholar